Associations Between Cognitive and Gait Performance During Single- and Dual-Task Walking in People With Parkinson Disease Elizabeth L. Stegemöller, Jonathan P. Wilson, Audrey Hazamy, Mack C. Shelley, Michael S. Okun, Lori J.P. Altmann and Chris J. Hass PHYS THER. 2014; 94:757-766. Originally published online February 20, 2014 doi: 10.2522/ptj.20130251

The online version of this article, along with updated information and services, can be found online at: http://ptjournal.apta.org/content/94/6/757 Collections

This article, along with others on similar topics, appears in the following collection(s): Gait Disorders Parkinson Disease and Parkinsonian Disorders

e-Letters

To submit an e-Letter on this article, click here or click on "Submit a response" in the right-hand menu under "Responses" in the online version of this article.

E-mail alerts

Sign up here to receive free e-mail alerts

Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

Research Report Associations Between Cognitive and Gait Performance During Single- and Dual-Task Walking in People With Parkinson Disease Elizabeth L. Stegemo¨ller, Jonathan P. Wilson, Audrey Hazamy, Mack C. Shelley, Michael S. Okun, Lori J.P. Altmann, Chris J. Hass

Background. Cognitive impairments in Parkinson disease (PD) manifest as deficits in speed of processing, working memory, and executive function and attention abilities. The gait impairment in PD is well documented to include reduced speed, shortened step lengths, and increased step-to-step variability. However, there is a paucity of research examining the relationship between overground walking and cognitive performance in people with PD. Objective. This study sought to examine the relationship between both the mean

E.L. Stegemo¨ller, PhD, Department of Kinesiology, Iowa State University, Ames, Iowa, and Department of Applied Physiology and Kinesiology and Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, Florida. Mailing address: 235 Forker, Ames, IA 50011 (USA). Address all correspondence to Dr Stegemo¨ller at: [email protected]. J.P. Wilson, PhD, Department of Speech Language and Hearing Sciences, University of Florida. A. Hazamy, MS, Department of Speech Language and Hearing Sciences, University of Florida.

and variability of gait spatiotemporal parameters and cognitive performance across a broad range of cognitive domains.

M.C. Shelley, PhD, Departments of Statistics and Political Science, Iowa State University.

Design. A cross-sectional design was used.

M.S. Okun, MD, Center for Movement Disorders and Neurorestoration, University of Florida.

Methods. Thirty-five participants with no dementia and diagnosed with idiopathic PD completed a battery of 12 cognitive tests that yielded 3 orthogonal factors: processing speed, working memory, and executive function and attention. Participants completed 10 trials of overground walking (single-task walking) and 5 trials of overground walking while counting backward by 3’s (dual-task walking).

L.J.P. Altmann, PhD, Department of Speech Language and Hearing Sciences and Center for Movement Disorders and Neurorestoration, University of Florida.

Results. All gait measures were impaired by the dual task. Cognitive processing

C.J. Hass, PhD, Department of Applied Physiology and Kinesiology and Center for Movement Disorders and Neurorestoration, University of Florida.

speed correlated with stride length and walking speed. Executive function correlated with step width variability. There were no significant associations with working memory. Regression models relating speed of processing to gait spatiotemporal variables revealed that including dual-task costs in the model significantly improved the fit of the model.

Limitations. Participants with PD were tested only in the on-medication state. Conclusions. Different characteristics of gait are related to distinct types of cognitive processing, which may be differentially affected by dual-task walking due to the pathology of PD.

[Stegemo¨ller EL, Wilson JP, Hazamy A, et al. Associations between cognitive and gait performance during single- and dualtask walking in people with Parkinson disease. Phys Ther. 2014;94: 757–766.] © 2014 American Physical Therapy Association Published Ahead of Print: February 20, 2014 Accepted: February 14, 2014 Submitted: June 16, 2013

Post a Rapid Response to this article at: ptjournal.apta.org June 2014

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

Physical Therapy f

757

Cognitive and Gait Performance in Parkinson Disease

B

etween 25% and 80% of people with Parkinson disease (PD) develop cognitive impairments.1–3 Declines in cognitive performance are associated with the risk of mortality, declines in social interaction, and limited performance of instrumental activities of daily living.4 Moreover, declines in cognitive performance do not reliably respond to available pharmacological and surgical treatments for PD, suggesting that nondopaminergic pathways may be a contributing factor.5,6 Recent research also has suggested the involvement of nondopaminergic pathways in gait dysfunction in people with PD.7 Thus, examining the relationship between cognitive and gait performance in people with PD may provide further insight into shared neural substrates that may clarify the etiology, progression, and treatment of the disease. The purpose of this study was to examine the relationship between cognitive

and gait performance in individuals with mild to moderate PD. Most of the literature examining the relationship between cognition and gait performance in people with PD has focused on changes in gait performance while walking and completing a secondary cognitive task (dual task).8 –11 Studies that examined walking while talking have demonstrated greater reductions in stride length and walking speed as the syntactic and phonological complexity of repeated sentences increased.8,9 Yogev and colleagues10 similarly found that gait speed decreased during a dual task (walking and counting backward) in both PD and healthy older adult control groups. However, gait variability significantly increased with a dual task in the PD group only.10 Yogev and colleagues10 suggested that a change in gait speed (and most likely stride length, as reported in previous stud-

The Bottom Line What do we already know about this topic? We know that people with Parkinson disease (PD) demonstrate both cognitive and walking impairments, but there is little information about the associations between these 2 impairments in PD.

What new information does this study offer? New information from this study suggests that the slowing of overall processing speed may indicate a shared neural system underlying walking and cognitive performance. In contrast, the association between executive function/attention performance and step width variability of walking may suggest the involvement of overlapping systems that require the prioritization of either cognitive or walking performance.

If you’re a patient, what might these findings mean for you? These findings suggest that strategies designed to increase overall processing speed may benefit both walking and cognitive processes, and strategies that target switching between walking and cognitive tasks may minimize the risk of falling in people with PD.

758

f

Physical Therapy

ies8,9) is a normal protective response to dual tasking in both PD and healthy older adults and is related to increased attention demands during the dual task. Changes in variability, however, reflect the possibility that regulating stride-to-stride variability is no longer an automatic process in PD but has become an attention-demanding task.10 Age-related changes in gait speed and variability during simple overground walking (single-task walking) in healthy older adults challenge this theory. In well-functioning older adults, slower gait speeds during single-task walking are associated with decrements in executive function and memory.12,13 Beauchet and colleagues14 have shown that lower scores in information updating and monitoring are related to increased stride time variability during singletask walking among healthy older adults. This finding suggests that cognitive functions play an important role even when a person is walking without an additional cognitive load, potentially through overlapping neural systems. Yet, there is limited research examining the relationship between single-task walking and cognitive performance in people with PD. Moreover, cognitive impairments in PD manifest as deficits in speed of processing and working memory (ie, the simultaneous storage and manipulation of information) as well as executive function and attention abilities.15,16 Examination of a wider array of both gait and cognitive parameters across both single-task and dual-task walking conditions is needed to obtain greater insight into the relationship between cognitive and gait performance in people with PD. In this study, we used correlation and regression analyses to compare gait spatiotemporal and variability measures and cognitive measures

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

June 2014

Cognitive and Gait Performance in Parkinson Disease across a broad range of cognitive domains (processing speed, working memory, and executive function and attention) during single-task and dual-task walking conditions in people with mild to moderate PD. We hypothesized: (1) that decrements in both spatiotemporal gait parameters and gait variability would be associated with declines in all aspects of cognitive performance, executive function and attention, working memory, and speed of processing during single-task walking and (2) that the inclusion of dual-task costs on walking would strengthen these relationships.

Table 1. Participant Demographicsa Variable

X (SD)/Total n (%)

Range

66.2 (8.5)

46–85

Demographic variables Age (y) Sex (m/f) Height (cm)

June 2014

152.4–187.9

79.6 (12.0)

52.3–105.4

Education (y)

17.4 (4.3)

10–28

MMSE Disease duration (y)

29.2 (1.0)

26–30

4.8 (4.5)

0.5–18

UPDRS

37 (10)

18–55

UPDRS motor

24 (7)

12–36

H&Y

Cognitive Assessment Each participant completed a battery of cognitive tests to examine performance across domains of processing speed, visual and verbal working

171.2 (7.7)

Weight (kg)

Clinical variables

Method Participants Thirty-five individuals diagnosed with idiopathic PD by a movement disorders–trained neurologist participated in the study. All participants were on a stable regimen of antiparkinsonian medication (⬎30 days) and were tested in the on-medication state. All participants reported they were fully responding to their medication at the time of testing. Participants with significant cognitive impairment (Mini-Mental State Examination [MMSE] score ⱕ24), a history of psychiatric disturbance (eg, major depressive disorder or generalized anxiety), falls (ie, a score ⬎1 on the Unified Parkinson’s Disease Rating Scale [UPDRS] item 13), cardiovascular disease, or severe unpredictable or painful episodes of motor fluctuation were excluded from the study. All participants were able to ambulate independently and did not wear orthotic or other corrective devices. Participant demographics are shown in Table 1. All participants signed an approved informed consent statement before the study.

28/7

Stage 1 Stage 1.5

2.1 (0.5)

5 (14.3%)

Stage 2

15 (42.8%)

Stage 2.5

11 (31.4%)

Stage 3

1–3.0

3 (8.6%)

1 (2.9%)

a

MMSE⫽Mini-Mental State Examination, UPDRS⫽Unified Parkinson’s Disease Rating Scale, H&Y⫽Hoehn & Yahr scale.

memory, and executive function and attention (Tab. 2). This battery of testing included traditional neuropsychological measures routinely assessed in individuals with PD. All cognitive tests were presented on a computer monitor in a fixed order to manage frustration associated with task difficulty. See Table 2 for descriptions of each task.17–22

digit span tasks yielded the highest loadings. Higher scores indicate better working memory. For factor 3 (executive function and attention), Stroop XXX reaction time and accuracy on the 2-back, visual working memory, and digit symbol substitution yielded the highest loadings. Higher scores indicate better executive function and attention.

Cognitive measures were entered into a principal components analysis using varimax rotation to obtain orthogonal factors suitable for use in linear regression. This analysis yielded 3 distinct factors (Tab. 2). For factor 1 (processing speed), response times in the star task, digit symbol substitution, Stroop colorword, Stroop index, and 0-back and 1-back tasks yielded the highest loadings. Higher scores indicate longer (ie, poorer) processing times. For factor 2 (working memory), accuracy on the operation span and both

Gait Assessment Participants completed 10 trials of barefoot overground walking along a 12-m walkway at their self-selected speed (single task) and 5 trials of barefoot overground walking while counting backward from a 3-digit number by 3’s (dual task).10,23 Participants did not use assistive devices during the gait assessment and were given rest between trials when requested by the participant. Thirtyfive retroreflective markers were placed over anatomical bony landmarks according to the Vicon Plug-

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

Physical Therapy f

759

Cognitive and Gait Performance in Parkinson Disease Table 2. Descriptive Statistics and Task Description for Cognitive Measures Task

X (SD)

Range

0.5 (0.2)

0.3–0.9

A large blue star appeared at variable interstimulus intervals. Participants verbally responded “Go” as soon as the star appeared.

Digit symbol substitution (s)a

2.9 (0.8)

1.6–5.0

Digit symbol substitution (accuracy)b

0.9 (0.2)

0.1–1.0

An array of nonverbal symbols (Korean alphabet) paired with single digits was presented. When a symbol appeared below the array, participants responded with the digit associated with the symbol. Accuracy was coded as the percentage of correct answers.16

Stroop XXX (s)b

0.6 (0.1)

0.5–1.2

Stroop color-word (s)a

0.9 (0.2)

0.7–1.6

Stroop index (s)a

0.3 (0.2)

0.01–0.9

0-back (s)a

0.7 (0.2)

0.5–1.2

Star task (s)

1-back (s)

a

a

0.4–2.7

0.8 (0.2)

0.1–1.0

Operation span (n)c

2.6 (1.2)

1–5.7

A nonmeaningful 6-consonant string of letters was presented on the screen. Following the string of letters, 1–4 single-step arithmetic problems were presented on a screen. Participants verified the arithmetic solution for each problem presented (eg, 3⫹2⫽5 for a “yes” response and 3⫹2⫽1 for a “no” response) and then recalled the 6-consonant string of letters in order. The average number of correct letters recalled in correct order was calculated.19

8.2 (2.1)

5–13

6.3 (2.0)

4–11

Particpants repeated increasingly long lists of single digits in forward and reverse order. The maximum number of lists recalled correctly of 14 was recorded.20

0.8 (0.2)

0.1–1.0

c

Visual working memory (accuracy)b

c

0-back task: A single tic-tac-toe target figure was presented. Participants responded “yes” or “no” to indicate whether they believed subsequent figures matched the target figure. 1-back task: Participants responded “yes” or “no” to indicated whether they believed a subsequent tic-tac-toe figure matched the figure immediately before. Accuracy was at ceiling on both the 0- and 1-back tasks, so response times were used as the dependent variable for these tasks. 2-back task: Participants responded “yes” or “no” to indicate whether they believed a subsequent tic-tac-toe figure matched the figure viewed 2 screens before. The percentage of correct “yes” responses was calculated.18

0.9 (0.40

Digit span backward (n)

b

Stroop XXX: Participants named, as quickly as possible, the color (red, blue, or green) of 4 X’s as they appeared on a screen. Stroop color-word: a series of color words displayed in incongruent colors (eg, the word red presented in green) were presented. Participants named the color as quickly as possible. Stroop index: The Stroop index was calculated as the difference between response times from the Stroop color-word and Stroop XXX tasks.17

2-back (accuracy)b

Digit span forward (n)c

a

Task Description

A series of tic-tac-toe figures (1–4 figures) were presented 1 at a time, followed by an array showing the same number of figures. Participants responded “yes” or “no” to indicate whether they believed the array of figures matched and was in the same order as the previously presented series of figures. The percentage of correct trials was calculated.21

Processing speed factor. Executive function and attention factor. Working memory factor.

760

f

Physical Therapy

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

June 2014

Cognitive and Gait Performance in Parkinson Disease in-Gait marker system (Vicon Nexus, Lake Forest, California). Kinematic data were collected at a sampling frequency of 120 Hz using a 10-camera motion capture system. Stride time, stride length, step width, swing time, and walking speed were calculated using standard definitions according to an algorithm programmed in Matlab (The Mathworks Inc, Natick, Massachusetts). The coefficient of variation (CV) (CV⫽SD/mean ⫻ 100%) was calculated to determine within-subject variability of stride time, stride length, step width, and swing time.24 To measure the change in gait due to a simultaneous cognitive task, dualtask cost was calculated as the log transformed (to normalize for skewed variables) ratio of dual-task to single-task value for each gait outcome measure.23 Data Analysis A 1-way repeated-measures multivariate analysis of variance was completed to examine differences in gait between single- and dual-task walking. Bivariate Pearson correlation analyses described the strength of the association between cognitive factors and gait variables during the single-task walking condition. Correlations between cognitive factors and dual-task cost also were calculated to examine whether changes in gait due to dual-tasking effects are associated with cognitive performance. Multiple correlations were corrected with Bonferroni adjustments. Finally, to examine how dualtask walking affects the relationship between gait and cognitive performance, a block regression analysis was completed. To control for collinearity among the variables, the single-task gait spatiotemporal measures, single-task gait variability measures, and dual-task cost measures were each entered into separate principal components analyses using varimax rotation to obtain orthogonal factors suitable for use in the June 2014

block regression. The single-task gait factors were entered first (model 1) followed by the dual-task cost factors (model 2) as predictors for each cognitive factor. The change in R2 values was evaluated. Separate regressions were completed for gait spatiotemporal and variability measures. Statistical analyses were performed using SPSS Statistics version 17.0 (SPSS Inc, Chicago, Illinois). Statistical significance was set at alpha ⬍.05. Role of the Funding Source This study was supported by the National Institute of Aging (grant R21AG0033284-1A2).

Results Associations Between Cognitive Factors and Gait Measures Table 3 shows the bivariate Pearson correlations between cognitive factors, single-task gait spatiotemporal and variability measures, and dualtask cost. Results revealed significant moderate to strong (rⱕ.5) associations between the processing speed factor and stride length and walking speed. There were no significant associations between working memory or executive function/attention factors and gait spatiotemporal measures. Specifically, for the single-task condition, slower processing speed times were associated with shorter stride length and slower walking speed. A significant moderate to strong (rⱕ.5) negative association between the executive function and attention factor and step width variability was revealed. Thus, less accurate executive function/attention scores were associated with increased step width variability. There were no other significant associations between the processing speed or working memory factors and gait variability measures. Single-Task Versus Dual-Task Walking Participants walked slower with shorter steps while spending more

time with both feet on the ground during the dual-task condition (Tab. 4). Furthermore, all dual-task costs document a pattern of reduced walking performance (Tab. 4). Interestingly, the analyses, when corrected for multiple comparisons, revealed a significant negative association between the processing speed factor and dual-task cost for only stride length. Given that the mean dual-task cost was negative, this finding would indicate that people with slower cognitive processing speeds experienced greater decrease in stride length in the dual task compared with people with faster processing speeds. No associations with dual-task cost were revealed for the working memory or executive function and attention factors. Block regression models revealed that both gait spatiotemporal and variability factors are significant predictors of processing speed and executive function and attention, but not of working memory. Moreover, results from the block regression revealed a significant increase in variance accounted for when dualtask cost factors were entered into the model predicting processing speed. Specifically, using both gait spatiotemporal factors as predictors of the processing speed factor, model 1 (single task only) accounted for 27% of the variance in processing speed, and model 2 (single-task plus dual-task cost) accounted for 45% of the variance (with a significant change in R2 values as measured by the F ratio, P⫽.002) (Tab. 5). In the model assessing gait variability factors, model 1 (single task only) accounted for 24% of the variance in processing speed, while including dual-task cost factors (model 2) increased the variance accounted for to 34% (with a significant change in R2 values as measured by the F ratio, P⫽.04). Therefore, single-task gait spatiotemporal and variability factors account for 27% and 23%,

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

Physical Therapy f

761

Cognitive and Gait Performance in Parkinson Disease Table 3. Correlations Between Cognitive Factors and Gait Parametersa Processing Speed Factor r (95% CI)

Variable

Working Memory Factor r (95% CI)

Executive Function and Attention Factor r (95% CI)

Stride time (s) Single-task cost

.14 (⫺.20 to .45)

.21 (⫺.13 to .51)

⫺.15 (⫺.46 to .19)

Dual-task cost

.20 (⫺.14 to .50)

⫺.11 (⫺.43 to .23)

⫺.29 (⫺.57 to .05)

Stride length (m) Single-task cost

⫺.54 (⫺.74 to ⫺.25)*

.13 (⫺.21 to .44)

⫺.26 (⫺.54 to .08)

Dual-task cost

⫺.55 (⫺.75 to ⫺.27)*

.29 (⫺.05 to .57)

.07 (⫺.27 to .39)

Step width (m) Single-task cost

.15 (⫺.19 to .46)

⫺.01 (⫺.34 to .32)

⫺.11 (⫺.43 to ⫺.51)

.08 (⫺.26 to .40)

Single-task cost

⫺.46 (⫺.69 to ⫺.15)

⫺.14 (⫺.45 to .20)

Dual-task cost

⫺.51 (⫺.72 to ⫺.21)

.19 (⫺.15 to .49)

Dual-task cost

.48 (.17 to .70)* .17 (⫺.17 to .48)

Swing time (%) ⫺.42 (⫺.66 to ⫺.10) .42 (.10 to .66)

Walking speed (m/s) Single-task cost

⫺.55 (⫺.75 to ⫺.27)*

Dual-task cost

⫺.48 (⫺.70 to ⫺.17)

⫺.01 (⫺.34 to .32)

⫺.15 (⫺.46 to .19)

.23 (⫺.11 to .52)

.23 (⫺.11 to .52)

Stride time variability (s) Single-task cost

.25 (⫺.09 to .54)

.24 (⫺.10 to .53)

⫺.08 (⫺.40 to .26)

Dual-task cost

.13 (⫺.21 to .44)

⫺.07 (⫺.39 to .27)

⫺.11 (⫺.43 to .23)

Single-task cost

.36 (.03 to .62)

⫺.10 (⫺.42 to .24)

⫺.09 (⫺.41 to .25)

Dual-task cost

.44 (.13 to .67)

⫺.30 (⫺.57 to .04)

⫺.04 (⫺.37 to .30)

Stride length variability (m)

Step width variability (m) .26 (⫺.08 to .54)

⫺.15 (⫺.46 to .19)

⫺.58 (⫺.76 to ⫺.31)*

⫺.03 (⫺.36 to .31)

⫺.01 (⫺.34 to .32)

.09 (⫺.25 to .41)

Single-task cost

.42 (.10 to .66)

⫺.24 (⫺.53 to .10)

.37 (.04 to .63)

Dual-task cost

.22 (⫺.12 to .51)

Single-task cost Dual-task cost Swing time variability (%)

a

.02 (⫺.31 to .35)

⫺.35 (⫺61 to ⫺.02)

95% CI⫽95% confidence interval. Asterisk denotes significance (P⬍.001). All comparisons were Bonferroni corrected for multiple comparisons.

respectively, of the variance in each model, and dual-task cost factors contributed an additional 28 and 10 percentage points, respectively (Tabs. 5 and 6). Therefore, the relationship between gait spatiotemporal and variability measures and processing speed was strengthened by inclusion of dual-task costs in the model. Regarding the executive function/ attention factor, entering both gait 762

f

Physical Therapy

spatiotemporal factors accounted for 14% of the variance in model 1 (single task only). The addition of the dual-task cost factor in model 2 accounted for an additional 8 percentage points of the variance; however, this change was not significant (P⫽.06) (Tab. 5). For the model assessing gait variability factors, the inclusion of dual-task costs did not significantly change the amount of variance accounted for (21% in model 1 compared with 17% in

model 2) (P⫽.85) (Tab. 6). This result suggests that the relationship between gait performance and executive function/attention in this group was not significantly affected by dual-task walking.

Discussion This study was the first to examine the relationship between a large battery of cognitive tests and multiple gait spatiotemporal and variability measures in people with mild to

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

June 2014

Cognitive and Gait Performance in Parkinson Disease Table 4. Descriptive Statistics for Gait Spatiotemporal Measures, Gait Variability Measures, and Dual-Task Costa Single Task Variable

X (SD)

Range

X (SD)

Range

P

X (SD)

Range

Stride time (s)

1.1 (0.1)

0.90 to 1.39

1.3 (0.3)

0.92 to 2.44

⬍.001*

0.06 (0.01)

⫺0.03 to 0.24

Stride length (m)

1.2 (0.2)

0.52 to 1.46

1.0 (0.2)

0.32 to 1.44

⬍.001*

⫺0.04 (0.008)

⫺0.20 to 0.01

0.03 (0.01)

⫺0.21 to 0.17

38.2 (2.5)

30.48 to 41.91

35.9 (3.1)

25.65 to 40.37

⬍.001*

⫺0.03 (0.004)

⫺0.10 to 0.01

Walking speed (m/s)

1.0 (0.2)

0.46 to 1.38

0.9 (0.2)

0.26 to 1.22

⬍.001*

⫺0.09 (0.01)

⫺0.34 to 0.03

Stride time variability (s)

0.03 (0.02)

0.01 to 0.10

0.08 (0.1)

0.02 to 0.67

.01*

0.32 (0.07)

⫺0.36 to 1.54

Stride length variability (m)

0.04 (0.02)

0.02 to 0.12

0.05 (0.04)

0.02 to 0.22

.06

Step width variability (m)

0.4 (0.2)

0.09 to 1.16

0.3 (0.1)

0.10 to 0.78

⬍.001*

Swing time variability (%)

0.04 (0.02)

0.02 to 0.12

0.06 (0.05)

0.02 to 0.28

.02*

Step width (m)

0.1 (0.03)

Swing time (%)

a

Dual-Task Cost Log10 (Dual/Single)

Dual Task

0.03 to 0.13

0.08 (0.03)

0.03 to 0.14

.002*

0.06 (0.04)

⫺0.55 to 0.52

⫺0.10 (0.02)

⫺0.45 to 0.23

0.14 (0.04)

⫺0.28 to 0.97

Asterisk denotes significance.

moderate PD who are taking medication. Our results revealed that in people with mild to moderate PD in the on-medication state, stride length and gait speed were significantly associated with processing speed measures, and step width variability was significantly associated with executive function and attention measures. There were no associations with the working memory factor. Moreover, these associations were affected differently by dual-task walking. These results suggest that temporal and postural aspects of gait may be related to different cognitive

domains, which can be differentially impaired by dual-task walking due to the pathology of PD.

were related to more temporal aspects of gait (ie, stride length and walking speed) were associated with processing speed. In contrast, gait variables related to postural aspects of gait (ie, step width variability) were associated with executive function/attention performance. These results are consistent with the previously proposed hypothesis that speed and temporal aspects of movement performance are controlled differently than postural aspects of movement performance.25 Furthermore, these findings suggest that these 2 dimensions of gait perfor-

Lord and colleagues25 have suggested that different control mechanisms may account for the temporal control of gait (stride time variability) and the postural control of gait (double stance time variability) in people with PD. Moreover, previous studies have reported that gait rhythmicity, rather than postural control, seems to improve preferentially with dopaminergic medication.26 In the current study, gait variables that

Table 5. Block Regression Model Predicting Cognitive Factors From Gait Spatiotemporal Parametersa Processing Speed Factor Model 1 Variable

B

Model 2

SE B



B

Executive Function and Attention Factor

Working Memory Factor Model 1

Model 2

Model 1



B

SE B



B

SE B



B

SE B



⫺7.17

7.70

5.32

7.42

Single task factor 1

⫺0.55

0.15

⫺0.55

⫺0.51

0.13

⫺0.51

0.03

0.17

0.03

0.001

0.17

0.001

Single task factor 2

0.10

0.15

0.10

⫺0.01

0.13

⫺0.01

0.22

0.17

0.22

0.30

0.17

0.30

⫺0.44

0.13

⫺0.44

3.15

0.17

3.15

Dual-task cost factor

Model 2

SE B

B

SE B



⫺0.89

0.43

9.12

0.05

0.96

⫺0.85

8.02

⫺0.15

13.59

5.82

0.36

Adjusted R2

.27

.45

⫺.01

.05

.14

.22

F change in R2

7.31

11.03

0.79

3.29

3.80

4.04

.46

.08

F change significance

.002*

.002*

.03*

.06

a Model 1 includes only single-task gait spatiotemporal factors (factor 1: stride length, swing time, walking speed; factor 2: stride time, step width), and model 2 adds the dual-task cost factor (all variables) as an additional predictor. SE⫽standard error. Asterisk denotes significance.

June 2014

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

Physical Therapy f

763

Cognitive and Gait Performance in Parkinson Disease Table 6. Block Regression Model for Cognitive Factors and Gait Variability Parametersa Processing Speed Factor Model 1

Working Memory Factor

Model 2

Model 1

B

SE B



B

SE B



Single task factor 1

0.51

0.15

0.51

0.57

0.14

Single task factor 2

0.16

0.15

0.16

0.06

Dual-task cost factor 1 Dual-task cost factor 2

Variable

Adjusted R2 F change in R2 F change significance

Executive Function and Attention Factor

Model 2

Model 1

Model 2

B

SE B



B

SE B



B

SE B



B

SE B



0.57

⫺0.15

0.17

⫺0.15

⫺0.17

0.18

⫺0.17

0.03

0.15

0.03

0.01

0.16

0.01

0.15

0.06

⫺0.25

0.17

⫺0.25

⫺0.23

0.18

⫺0.23

⫺0.50

0.15

⫺0.50

⫺0.52

0.17

⫺0.52

0.39

0.15

0.39

⫺0.09

0.18

⫺0.09

⫺0.03

0.17

⫺0.03

⫺0.01

0.15

⫺0.01

⫺0.04

0.18

⫺0.04

⫺0.09

0.16

⫺0.09

.24

.34

.03

⫺.02

.21

.17

6.33

3.52

1.50

0.16

5.50

0.16

.24

.85

.005*

.04*

.01*

.85

a Model 1 includes only single-task gait variability factors (factor 1: stride length variability, stride time variability, swing time variability; factor 2: step width variability), and model 2 adds the dual-task cost factors (factor 1: stride length variability cost, stride time variability cost, swing time variability cost; factor 2: step width variability cost) as an additional predictor. SE⫽standard error. Asterisk denotes significance.

mance share overlapping systems or pathologies with dissociable cognitive processes, speed of processing, and executive function and attention, respectively. Support for the hypothesis that temporal and postural components of gait performance are related to dissociable cognitive processes may come from neuroimaging studies. Processing speed has been consistently associated with white matter integrity in the frontal and parietal lobes.27–30 Both the frontal and parietal lobes have been implicated in the control of gait.31,32 In contrast, executive function has long been associated with activity in the prefrontal cortex in healthy adults and in people with PD.33,34 Cognitive tests specific to prefrontal function have been significantly associated with postural stability in patients with early to moderate PD.35 Thus, the associations between both stride length and walking speed and cognitive processing speed revealed in this study may potentially be accounted for by shared white matter networks connecting frontal and parietal regions, and the association 764

f

Physical Therapy

between executive function and step width variability may be due to overlapping systems in the prefrontal cortex. There were no significant associations in this study between the working memory factor and either singletask walking or dual-task costs. These results contrast with previous research demonstrating associations between working memory and gait performance in people with PD.36 This difference may be a reflection of the medication state of the participants tested. Previous research has shown that working memory deficits are improved with dopaminergic medication.37,38 Relationships between gait performance and working memory may not have been evident in this study because participants were tested on medication and were mildly to moderately affected by PD. The results of this study extend the findings of previous studies on dualtask effects on gait in people with PD, which similarly have demonstrated reductions in stride length and gait speed as well as increased

gait variability during dual-task walking in people with PD.8 –11,23 We additionally found changes in step width and step width variability during dual-task walking. Although most gait spatiotemporal and variability measures changed significantly during dual-task walking, only the change in stride length (dual-task cost) was significantly associated with the processing speed factor. Moreover, both gait spatiotemporal and variability measures were significant predictors of the processing speed factor and the executive function and attention factor. When comparing the change in variability accounted for by each model (change in R2 values), only the models predicting the processing speed factor significantly improved when the model included dual-task cost. Thus, processing speed was related to single-task walking as well as to the amount of change in walking due to the dual task. In contrast, the change in variation accounted for by the models was not significant for the executive function and attention model. A recent study by Wild and colleagues11 revealed associations between executive function and

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

June 2014

Cognitive and Gait Performance in Parkinson Disease attention measures and cognitive dual-task cost but not gait dual-task measures. Thus, changes in executive function and attention that occur in PD may affect single-task gait but do not disproportionately affect gait performance during the dual task. Taken together, these results suggest that the relationships between gait performance and processing speed and between gait performance and executive function and attention are differentially affected by dual tasking. Increases in stride time and swing time variability during dual-task walking have previously been associated with a greater risk of falls in people with PD.23 Moreover, changes in step width and step width variability during walking have been associated with a higher risk of falls in healthy older adults.39 – 41 In keeping with the hypothesis provided by Yogev and colleagues,10 a change in gait speed during a dual task may indeed be a normal protective response to the increased attention demand of dualtask walking in people with PD. However, our results suggest that dual-task changes in gait speed may be accompanied by other undesirable changes in step width and gait variability even in people with mild to moderate PD who rarely fall (UPDRS item 13⬍1), which may potentially increase the risk for falling during dual-task walking. However, whether dual-task walking and falls are related is beyond the scope of this study, as fall history was not collected. Nonetheless, our results suggest that further research is needed regarding the relationship between dual-task walking and falls in people with PD. Limitations Limitations of this study include the lack of a control group and testing in the on-medication state. The associations revealed in this study cannot June 2014

be fully attributed to PD but nonetheless provide positive insight into the relationship between gait and cognitive performance in people with PD. Because people with PD do not complete daily activities in the off-medication state, testing participants on medication provided information about how gait and cognitive performance are related in a participant’s daily functioning state. However, future studies examining the effects of medication on the associations revealed in this study are needed. Due to the multiple cognitive tests and length of the gait tests, fatigue may have affected both cognitive and gait performance. However, participants were given rest between cognitive tests and gait trials when requested. Moreover, the gait tasks were not randomized. Thus, practice effects for the dualtask walking condition may potentially confound the results. Participants walked barefoot for the gait assessment to remove potential confounds of different supportive shoes, but this approach may confound the ecologic validity of the walking tests used in this study. Although the results of this study revealed 2 distinct associations between gait and cognitive performance, no imaging data were collected to verify the speculative brain regions or pathology involved. In conclusion, the results of this study support the hypothesis that associations between cognitive and gait performance are dissociable and may be differentially affected by dual-task walking due to the pathology of PD. The slowing of overall processing speed may indicate a shared neural system underlying gait and cognitive performance that, when challenged by increasing cognitive load, affects both processes. In contrast, the association between executive function and attention performance and step width variability of gait may suggest the involve-

ment of overlapping systems that require the prioritization of either cognitive or gait performance due to limited resources in other brain areas affected by PD. These divergent associations should be taken into consideration when treating people with PD and suggest the importance of evaluating both cognitive and gait performance in people with PD. Walking in an everyday environment requires some level of dual tasking. Therefore, strategies designed to increase global processing speed may benefit both gait and cognitive processes, ultimately improving ambulation throughout the environment. Moreover, those people with PD demonstrating declines in executive function and attention may benefit from rehabilitation strategies that target switching between gait and cognitive tasks to minimize the risk of falls. Dr Stegemo¨ller, Dr Okun, Dr Altmann, and Dr Hass provided concept/idea/research design. Dr Stegemo¨ller, Dr Shelley, Dr Okun, Dr Altmann, and Dr Hass provided writing. Dr Stegemo¨ller, Mr Wilson, Ms Hazamy, Dr Altmann, and Dr Hass provided data collection. All authors provided data analysis. Dr Stegemo¨ller and Dr Hass provided project management. Dr Altmann and Dr Hass provided fund procurement. Dr Okun and Dr Hass provided study participants. Dr Okun, Dr Altmann, and Dr Hass provided facilities/ equipment. Dr Stegemo¨ller provided clerical support. Ms Hazamy provided consultation (including review of manuscript before submission). This research was presented at the Annual Meeting of the American Society for Biomechanics; September 4 –7, 2013; Omaha, Nebraska. This study was approved by the University of Florida’s Institutional Review Board. This study was supported by the National Institute of Aging (grant R21AG00332841A2). DOI: 10.2522/ptj.20130251

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

Physical Therapy f

765

Cognitive and Gait Performance in Parkinson Disease References 1 Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60:387–392. 2 Cummings JL. Intellectual impairment in Parkinson’s disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol. 1988;1:24 –36. 3 Pirozzolo FJ, Hansch EC, Mortimer JA, et al. Dementia in Parkinson disease: a neuropsychological analysis. Brain Cogn. 1982;1:71– 83. 4 Shipley BA, Der G, Taylor MD, Deary IJ. Cognition and mortality from the major causes of death: the Health and Lifestyle Survey. J Psychosom Res. 2008;65:143– 152. 5 Fournet N, Moreaud O, Roulin JL, et al. Working memory: evidence from attentive tracking and visual working memory paradigms. Neuropsychology. 2008;14:1119 – 1124. 6 Skeel RL, Crosson B, Nadeau SE, et al. Basal ganglia dysfunction, working memory, and sentence comprehension in patients with Parkinson’s disease. Neuropsychologia. 2001;39:962–971. 7 Rochester L, Yarnall AJ, Baker MR, et al. Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease. Brain. 2012;135:2779 –2788. 8 Morris M, Iansek R, Smithson F, Huxham F. Postural instability in Parkinson’s disease: a comparison with and without a concurrent task. Gait Posture. 2000;12: 205–216. 9 Rochester L, Hetherington V, Jones D, et al. Attending to the task: interference effects of functional tasks on walking in Parkinson’s disease and the roles of cognition, depression, fatigue, and balance. Arch Phys Med Rehabil. 2004;85:1578 – 1585. 10 Yogev G, Giladi N, Peretz C, et al. Dual tasking, gait rhythmicity, and Parkinson’s disease: which aspects of gait are attention demanding? Eur J Neurosci. 2005;22: 1248 –1256. 11 Wild LB, de Lima DB, Balardin JB, et al. Characterization of cognitive and motor performance during dual-tasking in healthy older adults and patients with Parkinson’s disease. J Neurol. 2013;260:580 – 589. 12 Watson NL, Rosano C, Boudreau RM, et al. Executive function, memory, and gait speed decline in well-functioning older adults. J Gerontol A Biol Sci Med Sci. 2010;65:1093–1100. 13 Ble A, Volpato S, Zuliani G, et al. Executive function correlates with walking speed in older persons: the InCHIANTI study. J Am Geriatr Soc. 2005;53:410 – 415. 14 Beauchet O, Annweiler C, MonteroOdasso M, et al. Gait control: a specific subdomain of executive function? J Neuroeng Rehabil. 2012;9:12. DOI:10.1186/ 1743– 0003-9 –12.

766

f

Physical Therapy

15 Saint-Cyr JA, Tre´panier LL, Kumar R, et al. Neuropsychological condequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain. 2000;123:2091–2108. 16 Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson’s disease: the cortical focus of neostriatal outflow. Brain. 1986;109:845– 883. 17 Lezak MD, Howieson DB, Loring DW, et al. Neuropsychological Assessment. 4th ed. Oxford, United Kingdom: Oxford University Press; 2004. 18 Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 2nd ed. New York, NY: Oxford University Press; 1998. 19 Braver TS, Cohen JD, Nystrom LE, et al. A parametric study of prefrontal cortex involvement in human working memory. Neuroimage. 1997;5:49 – 62. 20 Conway ARA, Kane MJ, Bunting MF, et al. Working memory span tasks: a methodological review and user’s guide. Psychon Bull Rev. 2005;12:769 –786. 21 Wechsler D. Wechsler Memory Scale⫺ Revised. New York, NY: Psychological Corp; 1987. 22 Fougnie D, Marois R. Distinct capacity limits for attention and working memory: evidence from attentive tracking and visual working memory paradigms. Psychol Sci. 2006;17:526 –534. 23 Plotnik M, Dagan Y, Gurevich T, et al. Effects of cognitive function on gait and dual tasking abilities in patients with Parkinson’s disease suffering from motor response fluctuations. Exp Brain Res. 2011;208:169 –179. 24 Wittwer JE, Andrews PT, Webster KE, Menz HB. Timing variability during gait initiation is increased in people with Alzheimer’s disease compared to controls. Dement Geriatr Cogn Disord. 2008;26: 277–283. 25 Lord S, Baker K, Nieuwboer A, et al. Gait variability in Parkinson’s disease: an indicator of non-dopaminergic contributors to gait dysfunction? J Neurol. 2011;258:566 – 572. 26 O’Sullivan JD, Said CM, Dillon LC, et al. Gait analysis in patients with Parkinson’s disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function. Mov Disord. 1998;13:900 –906. 27 van den Heuvel DM, ten Dam VH, de Craen AJ, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry. 2006;77:149 – 153. 28 Penke L, Mun ˜ oz Maniega S, Murray C, et al. A general factor of brain white matter integrity predicts information processing speed in healthy older people. J Neurosci. 2010;30:7569 –7574.

29 Turken AU, Whitfield-Gabrieli S, Bammer R, et al. Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. Neuroimage. 2008;42:1032–1044. 30 Sasson E, Doniger GM, Pasternak O, et al. White matter correlates of cognitive domains in normal aging with diffusion tensor imaging. Front Neurosci. 2013;7: 32. doi:10.3389/fnins.2013.00032. 31 Iseki K, Hanakawa T, Shinozaki J, et al. Neural mechanisms involved in mental imagery and observation of gait. Neuroimage. 2008;41:1021–1031. 32 Wang J, Wai Y, Weng Y, et al. Functional MRI in the assessment of cortical activation during gait-related imaginary tasks. J Neural Transm. 2009;116:1087–1092. 33 Ko JH, Antonelli F, Monchi O, et al. Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson’s disease. Hum Brain Mapp. 2013;34:1591– 1604. 34 Dirnberger G, Frith CD, Jahanshahi M. Executive dysfunction in Parkinson’s disease is associated with altered pallidalfrontal processing. Neuroimage. 2005;25: 588 –599. 35 Nocera JR, Price C, Fernandez HH, et al. Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson’s disease. Parkinsonism Relat Disord. 2010;16:590 –594. 36 Smulders K, van Nimwegen M, Munneke M, et al. Involvement of specific executive functions in mobility in Parkinson’s disease. Parkinsonism Relat Disord. 2013; 19:126 –128. 37 Cools R, Miyakawa A, Sheridan M, D’Esposito M. Enhanced frontal function in Parkinson’s disease. Brain. 2010;133(pt 1):225–233. 38 Lewis SJ, Slabosz A, Robbins TW, et al. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson’s disease. Neuropsychologia. 2005;43:823– 832. 39 McAndrew Young PM, Dingwill JB. Voluntarily changing step length or step width affects dynamic stability of human walking. Gait Posture. 2012;35:472– 477. 40 Nordin E, Moe-Nilssen R, Ramnemark A, Lundin-Olsson L. Changes in step-width during dual-task walking predicts falls. Gait Posture. 2010;32:92–97. 41 Ko SU, Gunter KB, Costello M, et al. Stride width discriminates gait of side-fallers compared to other-directed fallers during overground walking. J Aging Health. 2007;19:200 –212.

Volume 94 Number 6 Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

June 2014

Associations Between Cognitive and Gait Performance During Single- and Dual-Task Walking in People With Parkinson Disease Elizabeth L. Stegemöller, Jonathan P. Wilson, Audrey Hazamy, Mack C. Shelley, Michael S. Okun, Lori J.P. Altmann and Chris J. Hass PHYS THER. 2014; 94:757-766. Originally published online February 20, 2014 doi: 10.2522/ptj.20130251

References

This article cites 38 articles, 9 of which you can access for free at: http://ptjournal.apta.org/content/94/6/757#BIBL

Subscription Information

http://ptjournal.apta.org/subscriptions/

Permissions and Reprints http://ptjournal.apta.org/site/misc/terms.xhtml Information for Authors

http://ptjournal.apta.org/site/misc/ifora.xhtml

Downloaded from http://ptjournal.apta.org/ by guest on May 29, 2015

Associations between cognitive and gait performance during single- and dual-task walking in people with Parkinson disease.

Cognitive impairments in Parkinson disease (PD) manifest as deficits in speed of processing, working memory, and executive function and attention abil...
811KB Sizes 0 Downloads 3 Views